Ablation Technology Market

Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021

Report Code: MD 2738 Feb, 2017, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the Ablation Technology Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Ablation Technology Market

Request Now

[197 Pages Report] The global ablation technology market is estimated to be valued at USD 2.82 billion in 2016 and is expected to reach USD 4.73 billion by 2021, growing at a CAGR of 10.9% between 2016 and 2021. Emergence of next-generation ablation products and technologies, rising incidence of cancer, growing prevalence of cardiovascular diseases and increasing number of ablation procedures are the major factors driving the growth of the ablation technologies market during the forecast period.

Ablation Technologies Market

By type, the radiofrequency ablation segment is expected to be the largest contributor during the forecast period

On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the global market in 2016 due to lower cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management.

By product, the microwave ablators segment is expected to grow at the highest rate during the forecast period

Based on products, the market is segmented into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators. The microwave ablators segment is estimated to grow at the highest CAGR from 2016 to 2021. Highsuccess rate of microwave ablation in cancer treatment, as well as advantages offered by it over RF ablation (such as, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation), form the major factors contributing to the growth of this segment.

Ablation Technologies Market

By application, the cardiovascular disease segment is expected to be the largest contributor during the forecast period

By application, the market is further segmented into cardiovascular disease, pain management, cancer, ophthalmology, cosmetic surgery, gynecology, urology, orthopedics, and others. The cardiovascular disease segment is estimated to account for the largest share of the market in 2016. Rising incidence of atrial fibrillation across the globe coupled with the development of novel ablation technologies for the treatment of atrial fibrillation is the major factor driving the growth of the market.

North America dominated the market in 2016

North America is expected to command the largest share of the market in 2016, owing to the rapidly growing elderly population, high adoption rate of ablation devices in the region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period. The significant growth reported by the APAC region is propelled by factors including the growing focus of global market players, the large population base, and the rising prevalence of cancer.

Ablation Technologies Market

Medtronic, plc (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are some of the key players operating in the market.

Market Dynamics

Emergence of next-generation ablation products and significant adoption of minimally invasive procedures coupled with increasing number of ablation procedures are the key factors driving the growth of the global ablation technologies market. Furthermore, the rapidly increasing aging population with higher risk of target diseases and increasing number of hospitals, surgical, and ablation centers are also fueling the market growth.

However, ongoing healthcare reforms in the U.S. and cost-containment measures adopted by various governments are the key factors limiting the growth of this market. In addition, products recalls as well as therapeutic challenges related to efficacy of ablation products are the key challenges faced by industry players in the global ablation technologies market.

Driver: Increasing number of ablation procedures

Minimally invasive alternatives involve less pain, less scarring, and offer a quicker recovery for patients. Moreover, these procedures are more economical as compared to traditional surgical procedures. Globally, the acceptance of minimally invasive surgeries is increasing as these procedures are safer and have lower mortality as well as complication rates as compared to open surgeries (Source: Stanford University Medical Center Research).

The number of minimally invasive cosmetic procedures in the U.S. increased from ~13.9 million procedures in 2014 to 14.2 million in 2015 (Source: American Society for Aesthetic Plastic Surgery). Ablation is one of the most frequently used minimally-invasive techniques for the treatment of various tumor, AF, and uterine fibroids. Thus, the increasing demand for minimally invasive surgical procedures support the ablation procedures to increase worldwide and is driving the growth of the market.

Following are some important statistics in this regard:

  • Annually, over 200,000 ablation procedures are conducted on patients with AF who suffer from an irregular heart rhythm across the globe (Source: Boehringer Ingelheim GmbH)
  • The use of ablation for symptomatic AF has increased significantly over the past 10 years in the U.K. The procedural volume of cardiac ablation increased from 8,035 in 2007 to 17,106 in 2013 in the U.K. (Source: British Heart Rhythm Society)
  • The number of AF ablation procedures has increased from 79,000 in 2005 to 365,000 in 2013, globally

Restraint: Reuse and reprocessing of devices in developing countries

As per the FDA and EU guidelines, ablation catheters are labeled as single-use devices (SUDs). However, high per-unit cost of these devices and limited reimbursement has led to their reprocessing and reuse mainly in hospitals with budget constraints. The cost incurred by a hospital/surgical center for reprocessing and reuse is less than 10% as compared to the cost of a new ablation device, reducing the overall procedural cost by around 50%. Germany is among the key European countries which allows the reuse of SUDs (including ablation catheters), provided the devices are reprocessed as per the regulatory guidelines.

Due to lack of clear guidelines across the Asian and African countries, reprocessing and reuse of ablation catheters is common in these geographies. High cost of ablation devices have led to frequent reuse of these devices in developing countries such as Brazil, India, and Russia. Consequently, the reuse of ablation catheters decreases their market size, increases the risk of blood-borne infections among patients, and device malfunction.

Scope of the Report

Report Metric

Details

Market size available for years

2014–2021

Base year considered

2015

Forecast period

2016–2021

Forecast units

Value (USD)

Segments covered

Product, application, type, and region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW

Companies covered

Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc.
(U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan). 10 major players.

Scope of the Report

This research report categorizes the ablation technologies market into the following segments and sub-segments:

Global Ablation Technologies Market, by Type

  • Radiofrequency
  • Laser/Light
  • Ultrasound
  • Electrical
  • Cryoablation
  • Microwave
  • Hydrothermal

Global Ablation Technologies Market, by Product

  • Radiofrequency Ablators
    • Temperature-controlled Radiofrequency Ablators
    • Fluid-cooled Radiofrequency Ablators
    • Robotic Catheter Manipulation Systems
  • Laser/Light Ablators
    • Excimer Laser Ablators
    • Cold Laser Ablators
  • Ultrasound Ablators
    • High-intensity Focused Ultrasound (HIFU) Ablators
    • Magnetic Resonance-guided Focused Ultrasound (MRGFUS) Ablators
    • Ultrasonic Surgical Ablation Systems
    • Extracorporeal Shockwave Lithotripsy (ESWL) Systems
  • Electrical Ablators
    • Argon Plasma/Beam Coagulators
    • Irreversible Electroporation Ablators
  • Cryoablation Devices
    • Tissue Contact Probes
    • Tissue Spray Probes
    • Epidermal And Subcutaneous Cryoablation Devices
  • Microwave Ablators
    • Microwave Thermotherapy Devices
  • Hydrothermal Ablators
    • Endometrial Hydrothermal Balloon Ablation Devices

Global Ablation Technologies Market, by Application

  • Cardiovascular Disease
  • Cancer
  • Ophthalmology
  • Pain Management
  • Gynecology
  • Urology
  • Orthopedic Treatment
  • Cosmetic Surgery
  • Others

Others include fecal incontinence, gastroesophageal reflux disease (GERD), tonsillectomy, psoriasis, wound management, obstructive sleep apnea, and port wine stains

Global Ablation Technologies Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World

Key Market Players

In 2015, the global ablation technologies market is dominated by players, namely, Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), and AtriCure, Inc. (U.S.). Other key players in this market include CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan), among others.

Medtronic is one of the key global manufacturers of ablation products; with strong brand positioning across developed markets (such as the U.S., Japan, and Germany). To maintain its market positioning and expand its revenue base across the globe in the ablation devices market, Medtronic, plc focuses on product development, new product launches, and strategic acquisitions. In January 2015, Medtronic, Inc. acquired Covidien, plc, which helped it to enter developed markets, strengthen its product portfolio, and expand its geographic presence. This is among the key developments for the company.

Apart from acquisition, the company is significantly investing to strengthen its localized product development capabilities in emerging markets. Pertaining to this strategy, during 2013–2016, the company established several R&D centers across the Asian & Latin American markets, such as China, India, Brazil, and South Korea.

Additionally, Medtronic is constantly focusing on the development and commercialization of innovative ablation devices. In the last three years, Medtronic has launched several ablation products—Arctic Front Advance ST Cryoballoon, Emprint ablation System, Barrx Channel RFA Endoscopic Catheter, HALO90 ULTRA Ablation Catheter, and HALO60 ablation catheter, among others.

With its technologically advanced product portfolio, wide geographic presence in over 140 countries across the globe, and the acquisition of Covidien; Medtronic is expected to witness rapid growth in ablation segment during the forecast period.

Biosense Webster (a subsidiary of Johnson & Johnson) is among the leading players in the global ablation devices market. The company primarily focuses on strengthening its R&D capabilities to continuously develop and commercialize innovative ablation products in the global market. The company invested USD 9.04 billion (12.9% of its total sales) in R&D in 2015, which helped the company to launch technologically advanced products and maintain its position in the market. In the past three years, the company adopted product development and product launches as key business strategies. It launched several ablation products between 2016 and 2013, including THERMOCOOL SMARTTOUCH SF Catheter, CARTO 3 System CONFIDENSE module (June 2015), THERMOCOOL SMARTTOUCH Catheter (February 2014). Thus, with these initiatives to develop technologically advanced products, the company’s revenue from the ablation business segment is estimated to grow at a high rate in the future.  

Recent Developments:

  • In August 2016, Biosense Webster, Inc. launched its THERMOCOOL SMARTTOUCH SF Catheter in the U.S. for the treatment of drug resistant paroxysmal atrial fibrillation. This helped the company to expand its product portfolio and increase its revenue base in the U.S.
  • In May 2016, Galil Medical Inc. was acquired by the BTG plc group (a part of BTG International Ltd, U.K.); for a value of USD 110.0 million. BTG International is prominent manufacturer of cryoablation products and possesses strong product distribution network across Europe. The acquisition helped Galil Medical to strengthen its technological capabilities and to expand its distribution network in global ablation market.
  • In October 2016, Smith & Nephew established a new a sports medicine orthopedic devices manufacturing facility at Costa Rica with an investment of USD 55 million. This helped the company strengthen its product manufacturing capabilities and address the growing demand for ablation products in the ablation technologies market.
  • In December 2015, Medtronic entered into a partnership with Baylis Medical (Canada) to increase patient access to its OsteoCool RF Ablation System and further innovation in the system. Medtronic had acquired the OsteoCool technology and related IP from Baylis Medical in December 2015. This helped Medtronic to achieve technological advancement in its spinal tumor ablation system.
  • In April 2016, Abbott Laboratories and St. Jude Medical, Inc. entered into a merger agreement. As per the agreement Abbott will acquire St. Jude Medical by end of the 2016. This acquisition is expected to increase the global presence and capabilities of both the companies and diversify their product offerings in the medical devices industry. Additionally, the merger would create the industry-leading product pipeline and top position in the industry due to combined product portfolio.

Key questions addressed in the report:

  • What are the growth opportunities related to ablation technologies market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of ablation technologies products. Will this scenario continue in the next five years?
  • What are the various ablation technologies product segments and their market share in the overall market?
  • What are the new trends and advancements in the ablation technologies market?

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
Figure 1 Ablation Devices Market Research Methodology Steps
    2.2 Research Design
    2.3 Secondary and Primary Research Methodology
           2.3.1 Secondary Research
                    2.3.1.1 Key Data From Secondary Sources
           2.3.2 Primary Research
                    2.3.2.1 Key Data From Primary Sources
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
           2.3.3 Market Size Estimation Methodology
Figure 3 Research Methodology: Top-Down Approach
Figure 4 Research Methodology: Bottom-Up Approach
    2.4 Opportunity Indicators
           2.4.1 Demand-Side Analysis
                    2.4.1.1 Incidence and Prevalence of Cancer
Figure 5 Estimated Number of New Cancer Cases, By 2020 (Thousands)
                    2.4.1.2 Rapid Growth of Geriatric Population
Figure 6 Population Aged 65 and Above, By Region (In Million): 2015, 2030, and 2050
                    2.4.1.3 Significant Number of Clinical Researches in Ablation
Figure 7 Clinical Research Status in the Ablation Market 2017*
           2.4.2 Supply-Side Analysis
                    2.4.2.1 Clinical Trials By Ablation Technologies
Table 1 Clinical Research Status By Ablation Technology as of 2017*
                    2.4.2.2 Number of New Product Launches: Ablation Market  (2013–2016)
Figure 8 New Ablation Product Launches, 2013–2016
    2.5 Market Data Validation and Triangulation
Figure 9 Data Triangulation Methodology
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 34)
    3.1 Introduction
Figure 10 Ablation Technology Market Size, By Type (2016 vs 2021)
Figure 11 Ablation Technology Market Share, By Product (2016 vs 2021)
Figure 12 Ablation Technology Market Size, By Application (2016 Vs 2021
Figure 13 Ablation Technology Market Share, By Region (2016)
    3.2 Conclusion

4 Premium Insights (Page No. - 38)
    4.1 Global Ablation Technologies Market Overview
Figure 14 Rising Incidences of Cancer & Cardiac Diseases — Primary Driver of the Ablation Technology Market During
    4.2 Geographical Snapshot of the Global Ablation Technologies Market
Figure 15 India and China are the Most Lucrative Markets for Ablation Product Manufacturers
    4.3 Global Ablation Technologies Market, By Type  and Region
Figure 16 U.S. Commanded the Largest Share of the Ablation Technology Market in 2016
    4.4 Global Ablation Technologies Market, By Application
Figure 17 Cardiovascular Disease Treatment Segment to Dominate the Ablation Technology Market in 2021
    4.5 Global Ablation Technologies Market Size, By Product (2016 vs. 2021)
Figure 18 Radiofrequency Ablators Will Continue to Dominate the Market Till 2021

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
Figure 19 Ablation Devices Market Drivers, Restraints, Opportunities, and Challenges
           5.2.1 Drivers
                    5.2.1.1 Emergence of Next-Generation Ablation Products  and Technologies
                    5.2.1.2 Rising Incidence of Cancer
Figure 20 Global Prevalence of Cancer: Expected Trend Till 2020
                    5.2.1.3 Growing Prevalence of Cardiovascular Diseases
                    5.2.1.4 Increasing Number of Ablation Procedures
                    5.2.1.5 Increasing Number of Hospitals, Surgical, and Ablation Centers
           5.2.2 Restraints
                    5.2.2.1 Reuse and Reprocessing of Devices in Developing Countries
                    5.2.2.2 Healthcare Cost-Containment Measures
                    5.2.2.3 Unfavorable Regulatory Scenario
           5.2.3 Opportunities
                    5.2.3.1 Growth Potential Offered By Emerging Markets
                    5.2.3.2 Rising Awareness Related to Ablation Procedures
           5.2.4 Challenges
                    5.2.4.1 Product Recalls
                    5.2.4.2 Therapeutic Challenges

6 Industry Trends (Page No. - 50)
    6.1 Key Industry Trends: Ablation Market
           6.1.1 Industry Consolidation
Table 2 Major Merger & Acquisition Activities in the Ablation Technology Industry (2013–2016)
           6.1.2 Increasing Focus of Global Players Towards Developing Nations
           6.1.3 Increasing Funding for Ablation Product Development  and Commercialization
           6.1.4 Notable Developments in Microwave Ablation Segment
           6.1.5 High Focus of Market Players Towards Development of Advanced Radiofrequency Ablation Devices
    6.2 Reimbursement Scenario (Qualitative Insights)
    6.3 Supply Chain Analysis
    6.4 Porter’s Five Forces Analysis
Figure 21 Ablation Technology Market: Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers Intensity of Competitive Rivalry

7 Global Ablation Technologies Market, By Type (Page No. - 60)
    7.1 Introduction
Figure 22 Microwave Ablation Segment to Grow at the Highest Cagr During 2016 to 2021
Table 3 Global Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 4 Ablation Technology Market Size, By Region, 2014–2021 (USD Million)
    7.2 Radiofrequency Ablation
Table 5 Radiofrequency Ablation Market Size, By Region, 2014–2021 (USD Million)
    7.3 Laser/Light Ablation
Table 6 Laser/Light Ablation Market Size, By Region, 2014–2021 (USD Million)
    7.4 Ultrasound Ablation
Table 7 Ultrasound Ablation Market Size, By Region, 2014–2021 (USD Million)
    7.5 Electrical Ablation
Table 8 Electrical Ablation Market Size, By Region, 2014–2021 (USD Million)
    7.6 Cryoablation
Table 9 Cryoablation Market Size, By Region, 2014–2021 (USD Million)
    7.7 Microwave Ablation
Table 10 Microwave Ablation Market Size, By Region, 2014–2021 (USD Million)
    7.8 Hydrothermal Ablation
Table 11 Hydrothermal Ablation Market Size, By Region, 2014–2021 (USD Million)

8 Global Ablation Technologies Market, By Product (Page No. - 72)
    8.1 Introduction
Figure 23 Microwave Ablator is the Fastest-Growing Segment in the Global Market
Table 12 Global Ablation Technology Market Size, By Product, 2014–2021 (USD Million)
    8.2 Radiofrequency Ablators
Table 13 Radiofrequency Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 14 Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.2.1 Temperature-Controlled Radiofrequency Ablators
Table 15 Temperature-Controlled Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.2.2 Fluid-Cooled Radiofrequency Ablators
Table 16 Fluid-Cooled Radiofrequency Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.2.3 Robotic Catheter Manipulation Systems
Table 17 Robotic Catheter Manipulation Systems Market Size, By Region, 2014–2021 (USD Million)
    8.3 Laser/Light Ablators
Table 18 Laser/Light Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 19 Laser/Light Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.3.1 Excimer Laser Ablators
Table 20 Excimer Laser Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.3.2 Cold Laser Ablators
Table 21 Cold Laser Ablators Market Size, By Region, 2014–2021 (USD Million)
    8.4 Ultrasound Ablators
Table 22 Ultrasound Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 23 Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.4.1 Ultrasonic Surgical Ablation Systems
Table 24 Ultrasonic Surgical Ablation Systems Market Size, By Region, 2014–2021 (USD Million)
           8.4.2 High-Intensity Focused Ultrasound (Hifu) Ablators
Table 25 High-Intensity Focused Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.4.3 Extracorporeal Shockwave Lithotripsy (Eswl) Systems
Table 26 Extracorporeal Shockwave Lithotripsy Systems Market Size, By Region, 2014–2021 (USD Million)
           8.4.4 Magnetic Resonance-Guided Focused Ultrasound (Mrgfus) Ablators
Table 27 Magnetic Resonance-Guided Focused Ultrasound Ablators Market Size, By Region, 2014–2021 (USD Million)
    8.5 Electrical Ablators
Table 28 Electrical Ablators Market Size, By Product, 2014–2021 (USD Million)
Table 29 Electrical Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.5.1 Argon Plasma/Beam Coagulators
Table 30 Argon Plasma/Beam Coagulators Market Size, By Region, 2014–2021 (USD Million)
           8.5.2 Irreversible Electroporation Ablators
Table 31 Irreversible Electroporation Ablators Market Size, By Region, 2014–2021 (USD Million)
    8.6 Cryoablation Devices
Table 32 Cryoablation Devices Market Size, By Product, 2014–2021 (USD Million)
Table 33 Cryoablation Devices Market Size, By Region, 2014–2021 (USD Million)
           8.6.1 Tissue Contact Probes
Table 34 Tissue Contact Probes Market Size, By Region, 2014–2021 (USD Million)
           8.6.2 Tissue Spray Probes
Table 35 Tissue Spray Probes Market Size, By Region, 2014–2021 (USD Million)
           8.6.3 Epidermal and Subcutaneous Cryoablation Devices
Table 36 Epidermal and Subcutaneous Cryoablation Devices Market Size, By Region, 2014–2021 (USD Million)
    8.7 Microwave Ablators
Table 37 Microwave Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.7.1 Microwave Thermotherapy Devices
    8.8 Hydrothermal Ablators
Table 38 Hydrothermal Ablators Market Size, By Region, 2014–2021 (USD Million)
           8.8.1 Endometrial Hydrothermal Balloon Ablation Devices

9 Global Ablation Technologies Market, By Application (Page No. - 93)
    9.1 Introduction
Figure 24 Cardiovascular Disease Treatment Ablation Market to Grow at the Highest Cagr in the Forecast Period
Table 39 Global Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
    9.2 Cardiovascular Disease Treatment
Table 40 Ablation Technology Market Size for Cardiovascular Disease Treatment, By Region, 2014–2021 (USD Million)
    9.3 Cancer Treatment
Table 41 Ablation Technology Market Size for Cancer Treatment, By Region, 2014–2021(USD Million)
           9.3.1 Liver Cancer
           9.3.2 Kidney Cancer
           9.3.3 Prostate Cancer
           9.3.4 Lung Cancer
           9.3.5 Bone Metastasis
           9.3.6 Breast Cancer
    9.4 Ophthalmologic Treatment
Table 42 Ablation Technology Market Size for Ophthalmologic Treatment, By Region, 2014–2021 (USD Million)
    9.5 Pain Management
Table 43 Ablation Technology Market Size for Pain Management, By Region, 2014–2021 (USD Million)
    9.6 Gynecological Treatment
Table 44 Currently Approved Fda Ablation Technologies for Gynecological Treatment
Table 45 Ablation Technology Market Size for Gynecological Treatment, By Region, 2014–2021 (USD Million)
    9.7 Urological Treatment
Table 46 Ablation Technology Market Size for Urologic Treatment, By Region, 2014–2021(USD Million)
    9.8 Orthopedic Treatment
Figure 25 Number of Hip and Knee Replacement Surgeries, By Country: 2013
Table 47 Ablation Technology Market Size for Orthopedic Treatment, By Region, 2014–2021 (USD Million)
    9.9 Cosmetic/ Aesthetic Surgery
Table 48 Ablation Technology Market Size for Cosmetic/ Aesthetic Surgery, By Region, 2014–2021 (USD Million)
    9.1 Other Treatments
Table 49 Ablation Technology Market Size for Other Treatments, By Region, 2014–2021 (USD Million)

10 Global Ablation Technologies Market, By Region (Page No. - 109)
     10.1 Introduction
Figure 26 Global Ablation Technology Market Share, By Country (2016–2021)
Table 50 Global Ablation Technology Market Size, By Region, 2014–2021 (USD Million)
     10.2 North America
Figure 27 North America: Ablation Devices Market Snapshot
Table 51 North America: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 53 North America: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.2.1 U.S.
Table 54 U.S.: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 55 U.S.: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
                        10.2.1.1 Significant Volume of Ablation Procedures in the Country
                        10.2.1.2 Remarkable Adoption of Advanced Ablation Technologies as Compared to Conventional Technologies
                        10.2.1.3 Availability of Funding for Development of Novel Ablation Devices
             10.2.2 Canada
Table 56 Canada: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 57 Canada: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
     10.3 Europe
Figure 28 Europe: Ablation Devices Market Snapshot
Table 58 Europe: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 59 Europe: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 60 Europe: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.3.1 Germany
Table 61 Germany: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 62 Germany: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
                        10.3.1.1 Rising Focus of Market Players
                        10.3.1.2 Large Number of Ongoing Clinical Trials
                        10.3.1.3 Favorable Healthcare Reimbursement Scenario
                        10.3.1.4 Growing Incidence of Cancer and Cardiovascular Diseases
             10.3.2 France
                        10.3.2.1 Availability of Funding for Development of Novel Ablation Devices in the Country
                        10.3.2.2 Availability of Training Programs and Reimbursement for Certain Products in France
Table 63 France: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 64 France: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.3.3 U.K.
                        10.3.3.1 Large Patient Population Base
                        10.3.3.2 Availability of Research Funding
                        10.3.3.3 Expanding Presence of Market Players
                        10.3.3.4 Government Recommendations Encouraging Adoption of Ablation Technologies
Table 65 U.K.: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 66 U.K.: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.3.4 Italy
Table 67 Italy: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 68 Italy: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.3.5 Spain
Table 69 Spain: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 70 Spain: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.3.5 Rest of Europe
                        10.3.4.1 Rapidly Increasing Aging Population in the Region
                        10.3.4.2 Increasing Market Penetration of Leading Ablation Manufacturers in the Region
                        10.3.4.3 Prominent Adoption of Ablation in Italy
Table 71 Rest of Europe: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 72 Rest of Europe: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
     10.4 Asia-Pacific
Figure 29 Asia-Pacific: Ablation Devices Market Snapshot
Table 73 Asia-Pacific: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
                        10.4.1.1 Increasing Government Initiatives in the Region
                        10.4.1.2 Awareness Programs and Conferences in APAC
                        10.4.1.3 Rising Focus of Market Players
             10.4.2 Japan
                        10.4.2.1 Well-Developed Healthcare System
                        10.4.2.2 Rising Baby Boomer Population Coupled With Cancer Incidence in the Country
                        10.4.2.3 Rising Government Focus Towards the Development of the Medical Device Industry
Table 76 Japan: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 77 Japan: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.4.3 China
                        10.4.3.1 High Incidence of Target Diseases and Rapidly Aging Population
Table 78 China: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 79 Japan: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.4.4 India
                        10.4.4.1 Remarkable Patient Base in the Country
                        10.4.4.2 Improving Healthcare Infrastructure in the Country
                        10.4.4.3 Rising Focus of Global Players
Table 80 India: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 81 India: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.4.5 Australia
Table 82 Australia: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 83 Australia: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.4.6 South Korea
Table 84 South Korea: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 85 South Korea: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.4.7 Rest of Asia-Pacific
Table 86 Rest of APAC: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 87 Rest of APAC: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
     10.5 Rest of the World
Table 88 RoW: Ablation Technology Market Size, By Region, 2014–2021 (USD Million)
Table 89 RoW: Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table 90 RoW: Ablation Technology Market Size, By Application, 2014–2021 (USD Million)
             10.5.1 Latam
Table 91 Latam: Ablation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 92 Latam: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 93 Latam: Ablation Devices Market Size, By Application, 2014–2021 (USD Million)
             10.5.2 Middle East & Africa
Table 94 Mea: Ablation Technology Market Size, By Type, 2014–2021 (USD Million)
Table 95 Mea: Ablation Devices Market Size, By Application, 2014–2021 (USD Million)

11 Competitive Landscape (Page No. - 143)
     11.1 Overview
Figure 30 Leading Market Players Adopted New Product Launches & Approvals as Their Key Growth Strategy From 2013 to 2016
     11.2 Market Share Analysis
Figure 31 Global Ablation Technology Market Share, By Key Player, 2015
     11.3 Competitive Situation and Trends
Figure 32 New Product Launches & Approvals Was the Key Strategy
             11.3.1 New Product Launches & Approvals
Table 96 Top 5 New Product Launches & Approvals, 2012–2015
             11.3.2 Mergers & Acquisitions
Table 97 Mergers & Acquisitions, 2013–2016
             11.3.3 Geographical Expansions
Table 98 Geographical Expansions, 2014–2016
             11.3.4 Agreements and Joint Ventures
Table 99 Top 3 Agreements and Joint Ventures, 2013–2015
             11.3.5 Other Developments
Table 100 Top 5 Other Developments, 2014–2016

12Company Profiles (Page No. - 151)
(Overview, Products and Services, Financials, Strategy & Development)* 
     12.1 Introduction
Figure 33 Geographic Revenue Mix of Top Market Players
     12.2 Medtronic PLC
Figure 34 Medtronic PLC: Company Snapshot
     12.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
Figure 35 Johnson and Johnson: Company Snapshot
     12.4 St. Jude Medical, Inc.
Figure 36 St. Jude Medical, Inc.: Company Snapshot
     12.5 Boston Scientific Corporation
Figure 37 Boston Scientific Corporation: Company Snapshot
     12.6 Angiodynamics, Inc.
Figure 38 Angiodynamics, Inc.: Company Snapshot
     12.7 Atricure, Inc.
Figure 39 Atricure, Inc.: Company Snapshot
     12.8 Conmed Corporation
Figure 40 Conmed Corporation: Company Snapshot
     12.9 Olympus Corporation
Figure 41 Olympus Corporation: Company Snapshot
     12.1 Smith & Nephew
Figure 42 Smith & Nephew: Company Snapshot
     12.11 Galil Medical Inc. (Acquired By Btg International Ltd.)
Figure 43 Btg International Ltd. : Company Snapshot
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies. 

13 Appendix (Page No. - 185)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 2738
Published ON
Feb, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Ablation Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home